ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.

Huige Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.